Acupuncture may cool hot flashes in men on prostate cancer hormone therapy
NCT ID NCT07335224
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether acupuncture can reduce hot flashes and improve quality of life in men receiving hormone therapy for prostate cancer. Twenty-four men will be randomly assigned to start acupuncture right away or after a delay, and all will receive standard lifestyle advice. The main goal is to see if the acupuncture program is practical and acceptable, and to gather early data on its effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 24 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jan 2026
- Expected to finish
-
Jun 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Male participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Male * At least 18 years of age * Histologically or cytologically confirmed adenocarcinoma of prostate of any stage I-IV * Undergoing androgen deprivation therapy (ADT) and/or androgen receptor pathway inhibitors * Experiencing moderate to severe daily interference from hot flashes, as indicated by the Hot Flash Related Daily Interference Scale (score≥4) * Eastern Cooperative Oncology Group (ECOG) performance status of 0-1 * Able to read, understand, and provide written informed consent Exclusion Criteria: * Severe or uncontrolled concurrent disease, infection or co-morbidity that, in the opinion of the Investigator, would make the patient inappropriate for enrollment * Known hypersensitivity to the acupuncture needles * Any condition that in the opinion of the Investigator would impair the patients' ability to comply with the study procedures * Unable to comply with study requirements * Use of acupuncture for hot flashes within 6 months prior to enrollment
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Acupuncture therapy are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Inova Schar Cancer Institute
RECRUITINGFairfax, Virginia, 22031, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI spot which prostate cancers are safe to watch?
- Robotic surgery vs standard approaches: does the platform change cancer outcomes?
- Radiation boost may extend Drug-Free time in prostate cancer recurrence
- Can a simple blood test outsmart prostate cancer?
- Can a smart drug deliver a toxic payload to prostate cancer cells?
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards